Anthony Jarkowski
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
- Oncology 16
- Cancer Immunotherapy and Biomarkers 11
- CAR-T cell therapy research 3
- Peptidase Inhibition and Analysis 3
-
- Renal cell carcinoma treatment 4
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Alan Forrest (2 shared papers)Jenny C. Yang (1 shared paper)Lauren Lim (1 shared paper)Jürgen B. Bulitta (1 shared paper)Neang S. Ly (1 shared paper)Brian T. Tsuji (1 shared paper)Dana R. Anderson (1 shared paper)Nikhil I. Khushalani (7 shared papers)
- Journals
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (5 papers)Journal of Clinical Oncology (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)Annals of Oncology (2 papers)American Journal of Health-System Pharmacy (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Anthony Jarkowski
28 papers receiving 708 citations
Peers
Comparison fields: 5 of 84
- Molecular Medicine 238
- Applied Microbiology and Biotechnology 28
- Oncology 210
- Endocrinology 42
- Pharmacology 114
Countries citing papers authored by Anthony Jarkowski
This map shows the geographic impact of Anthony Jarkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Jarkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Jarkowski more than expected).
Fields of papers citing papers by Anthony Jarkowski
This network shows the impact of papers produced by Anthony Jarkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Jarkowski. The network helps show where Anthony Jarkowski may publish in the future.
Co-authors
The 25 scholars most cited alongside Anthony Jarkowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 345 | |
| 2 | 2014 | 84 | |
| 3 | 2017 | 24 | |
| 4 | 2009 | 22 | |
| 5 | 2008 | 21 | |
| 6 | 2011 | 20 | |
| 7 | 2013 | 19 | |
| 8 | 2020 | 19 | |
| 9 | 2015 | 19 | |
| 10 | 2012 | 18 | |
| 11 | 2014 | 17 | |
| 12 | 2008 | 15 | |
| 13 | 2017 | 14 | |
| 14 | 2014 | 10 | |
| 15 | 2014 | 9 | |
| 16 | 2015 | 9 | |
| 17 | Case report of pneumatosis intestinalis secondary to sunitinib treatment for refractory gastrointestinal stromal tumor. | 2011 | 9 |
| 18 | 2014 | 8 | |
| 19 | 2009 | 7 | |
| 20 | 2018 | 7 |
About Anthony Jarkowski
Anthony Jarkowski is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Otorhinolaryngology and Pathology and Forensic Medicine, having authored 28 papers that have together received 723 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Head and Neck Cancer Studies (4 papers), Renal cell carcinoma treatment (4 papers), Melanoma and MAPK Pathways (4 papers), CAR-T cell therapy research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Peptidase Inhibition and Analysis (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Molecular Medicine (238 citations), Applied Microbiology and Biotechnology (28 citations), Oncology (210 citations), Endocrinology (42 citations) and Pharmacology (114 citations). Anthony Jarkowski has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Alan Forrest, Jenny C. Yang, Lauren Lim, Jürgen B. Bulitta, Neang S. Ly, Brian T. Tsuji, Dana R. Anderson, Nikhil I. Khushalani, Michael K. Wong and John M. Kane. Their work appears in journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, Annals of Oncology and American Journal of Health-System Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.